6505-01-554-5301 ( 9317109002394 , 0548-1190-00 , 01722553 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-554-5301 | 6505 | 015545301 | LIDOCAINE HYDROCHLORIDE INJECTIO | 1015 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | CARTRIDGE-NEEDLE UNIT |
| CRXL | PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 1 BOX |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLIGRAMS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 PER CUBIC FOOT LIDOCAINE HYDROCHLORIDE PER 5 MILLILITERS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HCL INJECTION, USP, 2% (100 MG/5 ML) |
| CQGK | SECONDARY CONTAINER TYPE | BOX |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| 9317109002394 | Z0GL4 | A | 9 | 5 | 9 | ZA | |
| 0548-1190-00 | 54536 | A | 2 | 3 | 5 | 9Z | |
| 01722553 | Z0818 | A | 2 | 5 | 4 | ZA |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| 9317109002394 | Z0GL4 | GS1 AUSTRALIA PTY LTD | F | A |
| 0548-1190-00 | 54536 | INTERNATIONAL MEDICATION SYSTEMS | A | A |
| 01722553 | Z0818 | COMMONWEALTH SERUM LABORATORIES | E | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | 0 | X | A | 1 | 08/13/2 | A | P | 3004909120 | 1015 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|